Mumbai (Maharashtra) [India], September 15 (ANI): Equity benchmark indices traded higher with narrow gains during early hours on Tuesday amid positive sentiment across global markets.
New Delhi [India], September 12 (ANI): Hours after clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, pharma major Serum Institute of India (SII) said it will resume the trials in India once Drugs Controller General of India (DCGI) gives
New Delhi [India], September 12 (ANI): The Competition Commission of India (CCI) has approved the proposed combination involving the acquisition of 20 per cent of the issued and paid-up equity share capital of Piramal Pharma Limited (Pharma Co) by CA Clover Intermediate II Investments (Curie
Hyderabad (Telangana) [India], September 12 (ANI): The Anti-Corruption Bureau (ACB) has seized Rs 2.29 crore of unaccounted wealth of former director, Insurance Medical Services (IMS), Devika Rani and Naga Lakshmi, pharmacist.
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
New Delhi [India], Sep 10 (ANI): India's exports during the first week of September jumped 13.35 per cent year-on-year to 6.12 billion dollars, officials data released on Thursday showed.
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a show-cause notice Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
Mumbai (Maharashtra) [India], September 9 (ANI): Equity benchmark indices closed in the negative zone on Wednesday following losses in Asian markets after yesterday's rout in Wall Street.
Chandigarh (Punjab) [India] September 9 (ANI/NewsVoir): BSE listed CHD Chemicals Ltd, a chemicals and dyes manufacturing, trading, and distribution company has announced excellent unaudited financial results for the quarter ended June 30, 2020, wherein the company's turnover stood at Rs 4.74